Evidence map›Paper›PMID 32054011›Full record

ArticleMolecules (Basel, Switzerland)2020

Discovery of 9O-Substituted Palmatine Derivatives as a New Class of anti-COL1A1 Agents via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways.

Tianyun Fan, Maoxu Ge, Zhihao Guo, Hongwei He, Na Zhang, Yinghong Li, Danqing Song

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tianyun FanInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Maoxu GeInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Zhihao GuoInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Hongwei HeInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Na ZhangInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Yinghong LiInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Danqing SongInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

CAMS initiative for innovative medicine 2019I2M-1-001Chinese Pharmaceutical Association-Yiling Pharmaceutical Innovation Fund for Biomedicine GL-1-B04-20190397Fundamental Research Funds for the Central Universities 3332019083National Natural Science Foundation of China 81903695the Beijing Natural Science Foundation 7202131
6 · The paper itself

Abstract

Twenty 9O-substituted palmatine derivatives were prepared and tested for their biological effect against collagen α1 (I) (COL1A1) promotor in human hepatic stellate LX-2 cells. The structure-activity relationship (SAR) indicated that the introduction of a benzyl motif on the 9O atom was favorable for activity. Among them, compound 6c provided the highest inhibitory effect against COL1A1 with an IC

Indexed as

Berberine AlkaloidsCollagen Type ICollagen Type I, alpha 1 ChainDose-Response Relationship, DrugGene ExpressionHepatic Stellate CellsHumansJanus Kinase 1Models, BiologicalMolecular StructureSignal TransductionSmad ProteinsSTAT3 Transcription FactorStructure-Activity RelationshipTransforming Growth Factor beta1Berberine AlkaloidsCollagen Type ICollagen Type I, alpha 1 ChainJAK1 protein, humanJanus Kinase 1palmatineSmad ProteinsSTAT3 protein, humanSTAT3 Transcription FactorTransforming Growth Factor beta1COL1A1hepatic fibrosisJAK1/STAT3 pathwaypalmatinestructure−activity relationshipTGF-β1/smads pathway

Identifiers

PMID32054011
PMCPMC7070350
OpenAlexW3005605563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.